Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant TCX and Chemo-radiotherapy for Resected Gastric and GEJ Adenocarcinoma
NCT00718913Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Apr 2008
- Primary completion
- Sep 2009
- Modality
- Nanoparticles, DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132), capecitabine in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Hellenic Oncology Research Group. Started Apr 2008; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)capecitabine
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00718913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718913.